Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia

Recruiting N/A Interventional Study
Functional Dyspepsia Self-help Mobile Cognitive Behavioral Therapy Antipsychotic Drug
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
88 (estimated)
Sponsor
Air Force Military Medical University, China · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Functional dyspepsia (FD) is a common gastrointestinal disease, which is associated with decreased life quality and increased medical cost. Antipsychotic drugs were demonstrated to be effective in relieving symptoms in FD patients, especially for patients with refractory FD. However, the use of those drugs was associated with obvious adverse events. Cognitive behavioral therapy (CBT) has extensive…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age 18-80 2. Refractory functional dyspepsia (patients with Rome IV functional dyspepsia remained symptomatic after treatment of 8 weeks of proton pump inhibitor and 4 weeks of prokinetics) 3. Negative or unrelated-to-FD symptom findings of gastroscopy, upper abdominal ultras…
Contacts

Yanglin Pan, Professor

13991811225

yanglinpan@hotmail.com

CONTACT

Xiaoyu Kang, MD, Ph.D

15291680602

kangxiaoyu@hotmail.com

CONTACT